Prochlorperazine

Prochlorperazine maleate (Brown & Burk)

Tab 3 mg buccalNew ZealandFunded

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prochlorperazine

Prochlorperazine maleate (Brown & Burk)

Tab 3 mg buccalNew ZealandFunded

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

CompazineUnited States · 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Glaxosmithkline

EMETIRAL® 5 mg (vezi N05AB04)Romania · 5mg · compr. film. · Zentiva S.A.

EMETIRAL R 5mg (vezi A04ADN1)Romania · 5mg · compr. film. · Zentiva SA

Prochlorperazine Edisylate Injection USP 5MG/MLTaiwan · 注射劑 · 臺灣拜耳股份有限公司

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Prochlorperazine
Dosage form: Tab 3 mg buccal
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Community Pharmaceutical Schedule
Supply: Funded (PHARMAC)

PHARMAC

NausafixProchlorperazine · Tab 5 mgNew Zealand

StemetilProchlorperazine · Inj 12.5 mg per ml, 1 mlNew Zealand